Abstract
Gabapentin was used for the treatment of term and preterm infants with suspected visceral hyperalgesia caused by a variety of neurologic and gastrointestinal morbidities. Improved feeding tolerance and decreased irritability were seen, as well as decreased usage of opioids and benzodiazepines. Adverse events occurred with abrupt discontinuation of this medication.
Copyright © 2016 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Amines / administration & dosage*
-
Amines / adverse effects
-
Analgesics / administration & dosage*
-
Analgesics / adverse effects
-
Benzodiazepines / administration & dosage*
-
Benzodiazepines / adverse effects
-
Cyclohexanecarboxylic Acids / administration & dosage*
-
Cyclohexanecarboxylic Acids / adverse effects
-
Female
-
Gabapentin
-
Humans
-
Hyperalgesia / drug therapy*
-
Infant, Newborn
-
Intensive Care Units, Neonatal / statistics & numerical data*
-
Male
-
Retrospective Studies
-
gamma-Aminobutyric Acid / administration & dosage*
-
gamma-Aminobutyric Acid / adverse effects
Substances
-
Amines
-
Analgesics
-
Cyclohexanecarboxylic Acids
-
Benzodiazepines
-
gamma-Aminobutyric Acid
-
Gabapentin